Goldman Sachs GQG Partners International Opportunities Fund Institutional Shares (GSIMX) - Foreign Large Growth fund with $1.30 Billion in assets. The fund allocates 41.66% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Novo Nordisk A/S at 5.24% of total assets. This is followed by AstraZeneca PLC (4.75%) and Philip Morris International Inc (6.10%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Novo Nordisk A/S | 5.24% | - | - |
| AstraZeneca PLC | 4.75% | - | - |
| Philip Morris International Inc | 6.10% | - | - |
| NVIDIA Corp | 4.46% | - | - |
| SAP SE | 6.15% | - | - |
| TotalEnergies SE | 3.02% | - | - |
| Taiwan Semiconductor Manufacturing Co Ltd | 3.34% | - | - |
| Nestle SA | 3.07% | - | - |
| Novartis AG | 3.01% | - | - |
| Glencore PLC | 2.52% | - | - |
| Enbridge Inc | 3.29% | - | - |
| Goldman Sachs Financial Square Government Fund | 3.21% | - | - |
| Meta Platforms Inc | 2.56% | - | - |
| British American Tobacco PLC | 3.90% | - | - |
| Chubb Ltd | 3.58% | - | - |
| Iberdrola SA | 3.37% | - | - |